The Daily Hit: September 18, 2020 | How to order Skittles Moonrock online
Learn where to buy weed online. TOP QUALITY GRADE A++
Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.
👉 Click here to Visit our shop! 🛒
News from Missouri, California, the European Union, C3, and more.
The Daily Hit is an overview of the top financial stories for Wednesday, 18 September 2024.
On the Site
Missouri rolls back hemp ban and issues another cannabis recall
The Department of Health and Senior Services of the state will focus on “misbranded products” rather than intoxicating products.
The proposed California intoxicating-hemp ban may end up in court
Advocates claim that the new emergency rules will prevent access to high CBD products.
Banned C3 Team has a new IPO for Canadian Markets
The IPO was announced a day after the executives appealed the ban and fines.
Washington DC moves towards gray market cannabis crackdown
City leaders want to increase enforcement against so-called I-71 stores.
EU initiative opens access to psychedelic treatments
The initiative must gather 1 million signatures in a year for the European Commission to act.
Other News
Cannabis Cure
It is still unclear how the contaminated cannabis products reached the market one week after Maine regulators issued a recall for failing mold and fungus tests. The recall, which was announced last week, affects one strain of cannabis flowers and three strains pre-rolls. All were produced by Cannabis Cured a cultivator/retailer based in Fairfield.
Flora Growth Corp.
Flora Growth Corp. has entered into a strategic agreement with Blossom genetics to bring Colombian medicinal cannabis to the German Market.
Tilray
Tilray Medical is a division of Tilray Brands. On Wednesday, Tilray Medical announced that Redecan EU GMP certified medical cannabis products were now available to medical cannabis patients in Australia.
Leave a Reply
Want to join the discussion?Feel free to contribute!